Cargando…
Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D’Amico Intermediate-/High-Risk Prostate Cancer in Older Patients
SIMPLE SUMMARY: Androgen Deprivation Therapy (ADT) combined with radiotherapy is recommended for a duration of 6 months in unfavorable D’Amico intermediate-risk (IR) prostate cancer and a duration of 18 to 36 months in D’Amico high-risk (HR) prostate cancer. However, as patients ≥80 years are exclud...
Autores principales: | Couderc, Anne-Laure, Nicolas, Emanuel, Boissier, Romain, Boucekine, Mohammed, Bastide, Cyrille, Badinand, Delphine, Rossi, Dominique, Mugnier, Benedicte, Villani, Patrick, Karsenty, Gilles, Cowen, Didier, Lechevallier, Eric, Muracciole, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795189/ https://www.ncbi.nlm.nih.gov/pubmed/33383957 http://dx.doi.org/10.3390/cancers13010075 |
Ejemplares similares
-
HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial
por: Couderc, Anne-Laure, et al.
Publicado: (2022) -
Beyond D’Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier
por: Gabriele, Domenico, et al.
Publicado: (2016) -
The association of the type and number of D’Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2023) -
Analysis of outcome following robotic assisted radical prostatectomy for patients with high risk prostate cancer as per D’Amico classification
por: Gupta, Narmada Prasad, et al.
Publicado: (2016) -
L'amico ritrovato : romanzo
por: Uhlman, Fred